HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.

AbstractOBJECTIVE:
The goal of this study was to estimate the clinical activity of paclitaxel in patients with persistent or recurrent carcinosarcoma of the uterus who have failed other treatments.
METHODS:
The Gynecologic Oncology Group (GOG) conducted a phase II study of paclitaxel 170 mg/m(2) (135 mg/m(2) in those with prior irradiation) intravenously every 3 weeks in patients with histologic confirmation of carcinoma and measurable disease who had failed appropriate local therapy.
RESULTS:
A total of 53 patients were entered into the study between September 1994 and January 1997; 44 patients were evaluable for response. The median age of the patients treated was 65 years (range: 38-79). Twenty-six patients had heterologous mixed mesodermal tumors (MMTs) and 18 patients had homologous tumors. A median of three courses were administered (range: 1-18). Fifteen patients had previous radiation therapy and 33 patients had failed prior chemotherapy. Eight patients (18.2%) had a response to paclitaxel: four patients had a complete response and four had a partial response. Neutropenia was the most common toxic effect.
CONCLUSIONS:
Paclitaxel had moderate activity in patients with carcinosarcoma of the uterus. The GOG is currently studying the combination of paclitaxel and ifosfamide versus ifosfamide alone for patients with advanced or recurrent carcinosarcoma of the uterus.
AuthorsJ P Curtin, J A Blessing, J T Soper, K DeGeest
JournalGynecologic oncology (Gynecol Oncol) Vol. 83 Issue 2 Pg. 268-70 (Nov 2001) ISSN: 0090-8258 [Print] United States
PMID11606082 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright 2001 Academic Press.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Paclitaxel
Topics
  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic (adverse effects, therapeutic use)
  • Carcinosarcoma (drug therapy)
  • Drug Administration Schedule
  • Female
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy)
  • Paclitaxel (adverse effects, therapeutic use)
  • Uterine Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: